Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6 Springer Healthcare IME: Podcast to Practice Podcast

Episodi

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3
3 ott· Springer Healthcare IME: Podcast to Practice
Dr. Jennifer Green discusses breaking news and clinical implications of data presented at EASD 2024 on CGM technology use in type 2 diabetes.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
The effects of time on blood-based biomarkers | S1E7
15 ago· Springer Healthcare IME: Podcast to Practice
Petrice Cogswell summarizes research looking at temporal modelling of blood-based biomarkers and when to use them to predict brain amyloid deposition.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Episodi mancanti?

Fai clic qui per aggiornare il feed.
Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6
5 ago· Springer Healthcare IME: Podcast to Practice
Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Discussing the potential for blood based biomarker use | S1E5
5 ago· Springer Healthcare IME: Podcast to Practice
Rik Ossenkoppele discusses the latest research presented on blood-based biomarkers, including their accuracy for diagnosing Alzheimer’s disease and when best to use them.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Advances in therapies that work across multiple disease disciplines | S5E4
18 lug· Springer Healthcare IME: Podcast to Practice
Explore advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use with Professor Nilolaus Marx
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Improving integration of guidelines for CKD in T2D in clinical practice | S5E3
18 lug· Springer Healthcare IME: Podcast to Practice
Learn about evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice with Professor David Cherney
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Improving recognition, diagnosis and classification of CKD in T2D | S5E2
18 lug· Springer Healthcare IME: Podcast to Practice
Listen to Professor Pinar Topsever discuss the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers to recognition and diagnosis in practice.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
18 lug· Springer Healthcare IME: Podcast to Practice
Listen to Professor Tina Vilsbøll provide an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the importance of proactive identification and management.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2
4 lug· Springer Healthcare IME: Podcast to Practice
Dr. Eugene Wright, Jr. discusses breaking news and clinical implications of data presented at the ADA 2024 conference on CGM technology.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Optimal approaches for resectable ALK-driven NSCLC | S4E3
25 giu· Springer Healthcare IME: Podcast to Practice
Dr. Solange Peters shares invaluable insights into the management of ALK-positive NSCLC with a special focus on adjuvant therapy.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2
25 giu· Springer Healthcare IME: Podcast to Practice
Dr. Lizza Hendriks explores a complex case involving a 40-year-old male with ALK-rearranged non-small cell lung cancer (NSCLC).
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1
25 giu· Springer Healthcare IME: Podcast to Practice
Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an engaging patient case commentary.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Coping with PBC: Treatment challenges and QoL insights | S2E3
25 giu· Springer Healthcare IME: Podcast to Practice
Kris Kowdley meets with patient Sabrina Reeser as they discuss the patient experience of treatment for PBC, including treatment challenges, variability in doctor-patient communication and involvement in clinical trials.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1
17 apr· Springer Healthcare IME: Podcast to Practice
Dr. Rozalina McCoy discusses breaking news and clinical implications of data presented at the ATTD 2024 conference on CGM technology.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Walking the path of PBC: Navigating symptoms and QoL | S2E2
9 apr· Springer Healthcare IME: Podcast to Practice
David Jones meets with patient and patient advocate Mo Christie as they discuss the patient experience for PBC, including the burden of the disease and its impact on quality of life, with special reference to the common, and commonly misunderstood symptom, itch.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
The evolving landscape of PBC: New therapies and future directions | S2E1
9 apr· Springer Healthcare IME: Podcast to Practice
Kris Kowdley and David Jones share their insights on the evolving landscape of Primary Biliary Cholangitis (PBC), including new and upcoming therapy options, and how these may change practice for the disease
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Breakfast bites: Highlights from CONy 2024 | S1E4
25 mar· Springer Healthcare IME: Podcast to Practice
Professor Zvezdan Pirtošek comments on a session about whether lecanemab treatment should extend beyond 18 months.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Breakfast bites: Highlights from CONy 2024 | S1E3
25 mar· Springer Healthcare IME: Podcast to Practice
Professor Lea Grinberg explains research on how Alzheimer's Disease is linked to sleep disturbance, and whether interventions for bad sleep can stop tiredness as a risk factor.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Breakfast bites: Highlights from ADPD 2024™ | S1E2
13 mar· Springer Healthcare IME: Podcast to Practice
Professor Oskar Hansson summarises sessions from ADPD 2024™ on anti-amyloid immunotherapies
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi
Breakfast bites: Highlights from ADPD 2024™ | S1E1
12 mar· Springer Healthcare IME: Podcast to Practice
Professor Charlotte Teunissen summarises research presented at ADPD 2024™ about alzheimer's biomarkers, a novel assay for multiphosphorylated tau and the impact of confounding factors.
- Ascolta Ascolta di nuovo Continua Riproducendo…
- Ascolta più tardi Ascolta più tardi

Episodi

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3

The effects of time on blood-based biomarkers | S1E7

Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

Discussing the potential for blood based biomarker use | S1E5

Advances in therapies that work across multiple disease disciplines | S5E4

Improving integration of guidelines for CKD in T2D in clinical practice | S5E3

Improving recognition, diagnosis and classification of CKD in T2D | S5E2

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2

Optimal approaches for resectable ALK-driven NSCLC | S4E3

Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2

Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1

Coping with PBC: Treatment challenges and QoL insights | S2E3

Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1

Walking the path of PBC: Navigating symptoms and QoL | S2E2

The evolving landscape of PBC: New therapies and future directions | S2E1

Breakfast bites: Highlights from CONy 2024 | S1E4

Breakfast bites: Highlights from CONy 2024 | S1E3

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Breakfast bites: Highlights from ADPD 2024™ | S1E1